POLICY OF THE NATIONAL CANCER INSTITUTE FOR ALLOWABLE REQUESTED BUDGET LEVELS OF 
COMPETING CONTINUATION (TYPE 2) PROGRAM PROJECT (P01) GRANT APPLICATIONS

Release Date:  February 28, 2000

NOTICE:  CA-00-010

National Cancer Institute

To align more closely budgetary increases for P01 program project awards with 
overall NCI budget growth, beginning with the June 1, 2000 receipt date, 
budget requests for direct costs for NCI supported competing continuation 
(type 2) Program Project (P01) grant applications must not exceed an increase 
of 20% over the direct costs to be awarded in the last non-competing (Type 5) 
year.  Subsequent future year budget requests of competing continuations 
cannot, over the life of the proposed project, exceed simple inflationary 
adjustments.  This dollar total is exclusive of sub-contractual Facilities and 
Administrative (F&A) costs that appear as a direct cost in the budget of the 
applicant organization. 

Where currently active supplements have been awarded in conjunction with 
ongoing programs, the supplemental direct cost may be added into the base of 
the parent award if the work done under the supplement is to continue in the 
new project period. Regardless of peer reviewed recommended budgets, all 
awards still will be subject to any future overall NIH and NCI cost 
containment principles in effect at the time of an award.  After a competing 
award has been issued, awardees will continue to be eligible to apply for all 
competing and administrative program project supplements, even if the 
additional supplemental request exceeds the original cap.				
						

It is recognized that in some epidemiological or clinical research programs, 
the last non-competing year budget may be substantially lower than other 
previous years.  In such circumstances, if the nature of the new research 
requires budget increases for one or more interim years above the 20 percent 
rule for the last non-competing year, applicants may cite the most relevant 
prior budget year as a base for the new cap.  Such applicants are advised to 
contact the NCI program director for the currently funded grant for advice 
before submitting an application.  Prior approval of the NCI will be required 
before any application with a budget exceeding these guidelines can be 
accepted for review.  Competing continuation applications requesting increases 
in excess of these guidelines lacking such approval will be returned without 
review.

The full set of policies and procedures related to NCI P01 grants is available 
at the following location:  http://deainfo.nci.nih.gov/awards/P01.HTM 

INQUIRIES

For questions or further information, contact:

Dr. Virginia P. Wray
Chief, Research Programs Review Section
Grants Review Branch
Division of Extramural Activities
National Cancer Institute
6116 Executive Boulevard, Room 8125
Bethesda, MD  20892-8328
Telephone:  301.496.9236
FAX:  301.496.6497
Email:  vw8z@nih.gov

Return to Volume Index

Return to NIH Guide Main Index

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, RealPlayer, Video or Flash files, see Help Downloading Files.